Company
Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| WTX-124 | Phase 1 | Metastatic Solid Tumor |
Latest
Follow Werewolf Therapeutics, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.